Immunology

Uncommon Union: Lupus Nephritis and Lupus Erythematosus Tumidus

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on Oct. 4, 2023 A recent case study reports on the co-occurrence of lupus erythematosus tumidus and lupus nephritis—an extremely rare manifestation of lupus—in a 38-year-old woman.  Systemic lupus erythematosus (SLE) is known for its diverse array of clinical manifestations, encompassing various organ systems. Among these, lupus nephritis and...

CDC Recommends RSV Shot for All Infants

Vaccine has been shown to reduce the risk for both hospitalizations and health care visits for RSV in infants by about 80 percent. The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants younger than 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus...

Open-Label Placebo Versus Double-Blind Placebo and Treatment-as-Usual for Allergic Rhinitis

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 An open-label placebo alleviated seasonal allergy symptoms, whereas a conventional placebo had no effect. Allergic rhinitis symptoms fluctuate with seasonal allergen levels. There is evidence that placebos are effective as symptomatic treatments. New research challenges the idea that placebo effects need deception by...

Risk of Infant Egg Allergy in Breastfeeding Mothers

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 Maternal egg intake during the early neonatal period did not influence the development of immunoglobulin E-mediated egg allergy or sensitization to eggs in a recent study. Around 10% of children are believed to suffer from food allergies, which are rising rapidly. It has...

Recent Advancements in Shikonin for Treating Immune-Related Diseases

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 Shikonin, the primary active component of the traditional Chinese medicinal herb “ZiCao,” has exhibited a broad range of pharmacological effects, including anti-inflammatory, anti-tumor, and antioxidant activity. Recent research demonstrates its potential for treating immune-related inflammatory diseases like multiple sclerosis, asthma, lupus nephritis, and...

Biden Administration Launches Office for Long COVID Research

The Office of Long COVID Research and Practice will lead the U.S. response to long COVID, which includes trials that have already been launched. As Americans continue to grapple with the effects of long COVID, the Biden administration on Monday announced the creation of a new office focused on research about the condition that will...

Report Quantifies Misdiagnosis of Dangerous Diseases in the United States

Total serious harms extrapolated to affect 795,000 in U.S., with 15 dangerous diseases accounting for half of serious harms Misdiagnosis of dangerous diseases results in an estimated 795,000 Americans with permanent morbidity or mortality, according to a study published online July 17 in BMJ Quality & Safety. David E. Newman-Toker, M.D., Ph.D., from the Johns Hopkins...

COVID-19 May Have Spread Between Humans, Deer

Key Takeaways New evidence that coronavirus spreads between humans and deer heightens concern that animals could harbor new variants Humans spread SARS-CoV-2 more often to deer than vice versa in late 2021 and early 2022, the study found This animal reservoir could keep variants circulating even after their spread in people slows New research shows...

Long-Acting ART Achieves Virologic Suppression for People With HIV

97.5 percent were projected to achieve virologic suppression by a median of 33 weeks Long-acting antiretroviral therapy (LA-ART) can achieve virologic suppression among people with HIV (PWH), including those with viremia, according to a study published online July 4 in the Annals of Internal Medicine. Monica Gandhi, M.D., M.P.H., from the University of California in San...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.